EURAZEO (EPA:RF) | Finanzwire

Basculer en Français

8296	Companies
114905	Keywords
55332	Articles
62461	Press releases

Home
Companies
EURAZEO

REGULATED PRESS RELEASE

published on 11/18/2024 at 17:35, 2 days 20 hours ago

Disclosure of transactions in own shares on November 11 to November 15, 2024
REGULATED PRESS RELEASE

published on 11/12/2024 at 17:35, 8 days 20 hours ago

Disclosure of transactions in own shares on November 1 to November 8, 2024
BRIEF

published on 11/08/2024 at 17:40, 12 days 20 hours ago

EURAZEO's Voting Rights and Share Capital Information for October 2024

Share Capital Voting Rights Regulatory Compliance EURAZEO AMF
REGULATED PRESS RELEASE

published on 11/08/2024 at 17:35, 12 days 20 hours ago

Disclosure of the number of shares and the total number of voting rights as of October 31, 2024
Disclosure of the number of shares and voting rights by Eurazeo SE as of October 31, 2024 in compliance with French regulations. Eurazeo is a leading European investment group managing diversified assets

Voting Rights Shares Investment Group Eurazeo SE Assets
BRIEF

published on 11/06/2024 at 07:05, 15 days 6 hours ago

Eurazeo Achieves Strong Growth and Realizations in 2024

Portfolio Performance Asset Management Impact Investments Fundraising Growth Realizations Increase
REGULATED PRESS RELEASE

published on 11/06/2024 at 07:00, 15 days 6 hours ago

EURAZEO RECORDS DYNAMIC ASSET MANAGEMENT GROWTH AND A PICK-UP IN REALIZATIONS IN THE FIRST 9 MONTHS OF 2024, IN LINE WITH ITS STRATEGIC PLAN
Eurazeo reports dynamic asset management growth with €3bn fundraising (+76%) and pick-up in realizations. Strong portfolio company performance reflected in revenue growth. Progress in ESG and impact investments

EURAZEO Asset Management Fundraising ESG Realizations
REGULATED PRESS RELEASE

published on 10/31/2024 at 18:19, 20 days 19 hours ago

Disclosure of transactions in own shares on October 28 to October 31, 2024
REGULATED PRESS RELEASE

published on 10/28/2024 at 17:35, 23 days 20 hours ago

Disclosure of transactions in own shares on October 21 to October 25, 2024
REGULATED PRESS RELEASE

published on 10/21/2024 at 17:35, 30 days 20 hours ago

Disclosure of transactions in own shares on October 14 to October 18, 2024
REGULATED PRESS RELEASE

published on 10/14/2024 at 17:35, 1 month 6 days ago

Disclosure of transactions in own shares on October 7 to October 11, 2024

Accesswire

Published on 11/21/2024 at 13:30, 24 minutes ago

AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 24 minutes ago

Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 54 minutes ago

Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 54 minutes ago

Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 54 minutes ago

Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 13:15, 38 minutes ago

NOTICE OF ANNUAL GENERAL MEETING
Published on 11/21/2024 at 12:35, 1 hour 18 minutes ago

audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 38 minutes ago

Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 12:06, 1 hour 47 minutes ago

IVU AG publishes Quarterly Report Q3-2024
Published on 11/21/2024 at 12:00, 1 hour 53 minutes ago

Holding(s) in Company

Les Echos

Published on 11/21/2024 at 06:58, 6 hours 56 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 34 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 9 minutes ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 9 minutes ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE